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ABSTRACT: Enzymes typically depend on either 
NAD(P)H or FADH2 as hydride source for reduction 
purposes. In contrast, organometallic catalysts most 
often rely on isopropanol or formate to generate the 
reactive hydride moiety. Here we show that incorpora-
tion of a Cp*Ir cofactor possessing a biotin moiety and 
4,7-dihydroxy-1,10-phenanthroline into streptavidin 
(Sav) yields an NAD(P)H-dependent artificial transfer 
hydrogenase (ATHase). This ATHase (0.1 mol%) cata-
lyzes imine reduction with 1 mM NADPH (2 mol%), 
which can be concurrently regenerated by a glucose 
dehydrogenase (GDH) using only 1.2 equivalents glu-
cose. A four enzyme cascade consisting of the ATHase, 
the GDH, a monoamine oxidase and a catalase leads to 
the production of enantiopure amines. 
The introduction of synthetic catalysts into a biologi-
cal context is at the focus of current efforts in both syn-
thetic- and chemical biology.1,2 Goals include i) the 
supplementation of existing- or engineered metabolic 
pathways, ii) decaging inactive forms of enzymes to 
trigger enzymatic cascades,2,3 iii) shifting the redox 
equilibrium in cancer cells to induce apoptosis4 or iv) 
produce fuels with the help of biological redox equiva-
lents.3-5 Achieving high productivity of synthetic organ-
ometallic catalysts inside a living system remains chal-
lenging and progress is likely to be incremental.2,6 In 
contrast, the combination of isolated enzymes and transi-
tion metal catalysts in carefully designed in vitro sys-
tems of modest complexity experiences increasing suc-
cess.7-9  
Transition metal-mediated formal hydride transfer oc-
cupies a prominent role in many of these initiatives.9 
Remarkably, synthetic catalysts and enzymes have 
gained common ground for the conversion of ketones to 
alcohols, imines to amines (and vice versa), the reduc-
tion of activated double bonds and the racemisation of 
secondary alcohols and amines.10 A few isolated studies 
have shown that transition metal complexes can accept 
NAD(P)H as a hydride source.5,11,12 To the best of our 
knowledge however, their concurrent use coupled with 
enzymatic processes, where the hydride is utilized in a 
productive fashion, have not been disclosed yet (Scheme 
1a). We hypothesize that this may be traced back to the 
mutual deactivation of both transition metal catalysts 
and natural enzymes. To overcome this challenge, spa-
tial separation of both catalytic partners has proven most 
effective.13-15 In this context, artificial metalloenzymes 
(AMEs) have received increasing attention as alternative 
to both homogeneous catalysts and enzymes.16 To test 
the versatility of AMEs for the implementation of enzy-
matic cascades, we reported on the compartmentaliza-
tion of a biotinylated Cp*Ir-based transfer hydrogena-
tion catalyst into streptavidin (Sav) variants (Scheme 
1d).15 To drive the hydride transfer reactions at reasona-
ble rates however, concentrations of formate in the mo-
lar range were required.7,15,17 Such concentrations of 
formate may lead to inactivation of natural enzymes and 
are thus incompatible with in vivo applications. Here, we 
show that the biological reducing agent NAD(P)H can 
serve as an efficient hydride source for an Cp*Ir-
catalyzed hydride transfer in multienzymatic cascade 
reactions at millimolar loadings and near perfect stoichi-
ometric fidelity under concurrent enzymatic NAD(P)H 
regeneration.  
Scheme 1. (a) NAD(P)H as a hydride source for imine 
hydrogenation. Structure of (b) NAD+, (c) pianostool 
complexes (L^L is a bidentate ligand) and (d) sche-
matic representation of a Sav-based ATHase.  
  
In previous designs of artificial transfer hydrogenases 
(ATHase) based on d6-pianostool complexes, we relied 
on aminosulfonamide or aminoamide ligands to catalyze 
the transfer of hydride from formate to ketones, imines, 
enones18 and N-alkylated nicotinamides (Scheme 
1c).15,19 Inspired by Sadler’s work on the NADH oxida-
tion catalysts,11 we screened a range of commercial bi-
dentate ligands (L^L 1-27) for their ability to act as lig-
ands for Cp*Ir in the oxidation of dihydronicotinamides 
(NADH) in the presence of an acceptor substrate 
(Scheme 2a). The amount of consumed NADH was 
determined by absorbance spectroscopy in the presence 
of 1 eq. 1-methyl-3,4-dihydroisoquinoline (MDQ A 
hereafter), [Cp*IrCl2]2 (12.5 mol%) and L^L (27.5 
mol%) possessing various donor and acceptor properties 
(Scheme 2b and S1). Among the ligands displaying 
catalytic oxidation of NADH (> 25 % = 1 turnover), 
bisoxazoline 1 and phenanthroline ligands 2-5 gave the 
highest activities (Scheme 2b and Scheme S1). To dis-
tinguish competitive hydrogen evolution from substrate 
reduction, these ligands were employed in reactions with 
[Cp*IrCl2]2 (0.2 mol%), ligand L^L (0.44 mol%) and 
stoichiometric amount of NADH (25 mM). Formation of 
1-methyl-1,2,3,4-tetrahydroisoquinoline (MTQ B here-
after) was monitored by HPLC (Scheme 2c). The elec-
tron rich 4,7-dihydroxy-1,10-phenanthroline 5,20 and to 
a lesser extent the bioxazoline 1, led to significantly 
improved rates with respect to the product formation.  
Scheme 2. (a) NADH as hydride source for the reduc-
tion of MDQ A catalyzed by [Cp*Ir(L^L 1-27)Cl]. 
(b) Selected ligands and corresponding conversion of 
NADH into NAD+.  (c) Time-course plot of MDQ A 
hydrogenation by [Cp*IrCl2]2 with ligands 1 (blue), 2 
(orange), 3 (green), 4 (red) and 5 (cyan). 
 
Having identified the most promising bidentate ligand 
L^L 5, the corresponding ATHase [Biot-Cp*Ir(L^L 
5)Cl]⊂Sav was assembled (Scheme 1c, d).21-23 Next, we 
combined this ATHase with glucose dehydrogenase 
(GDH) to regenerate the consumed NAD(P)H. This 
enables the use of glucose as reductant, yielding 
NAD(P)H and glucono-δ-lactone (Scheme 3). The per-
formance of the concurrent enzymatic cascade was op-
timized by screening Sav variants focusing on close-
lying positions S112 and K121.22 The reactions con-
tained GDH (0.1 mg/ml), NAD+ (1 mM, 2 mol%), glu-
cose (60 mM, 120 mol%), Biot-Cp*Ir(L^L 5)Cl (50 µM, 
0.1 mol%), Sav free binding sites (100 µM) and MDQ A 
(50 mM). Compared to [Biot-Cp*Ir(L^L 5)Cl], the con-
version by [Biot-Cp*Ir(L^L 5)Cl]⊂Sav doubled, high-
lighting the shielding effect of the host protein (Scheme 
3, entries 1 and 2). Mutation at position S112 did not 
improve the performance of the ATHase and no activity 
was observed in the presence of coordinating aminoac-
ids at either S112 or K121 (Scheme 3, entries 3, 4 and 
Table S7, entries 1-6). The conservative mutation 
K121R afforded the most active ATHase [Biot-
Cp*Ir(L^L 5)Cl]⊂Sav K121R (Scheme 3, entry 5). Rais-
ing the temperature from 25 to 37°C and replacing 
NAD+ by NADP+ led to further improvements (Scheme 
3, entries 5-7). Finally, extending the reaction time from 
14 to 16 hours yielded full conversion, corresponding to 
TONIr = 1000 and to TONNADP+ = 50 (Scheme 3, entry 
8). Under these conditions, only 1.2 equivalents of glu-
cose are required to drive the imine reduction to comple-
tion.  Even under physiological NADP(H) concentra-
tions (i.e. 120 µM),24 a TONIr of 164 was obtained 
(Scheme 3, entry 9). The previously reported HCOOH-
dependent ATHase [Cp*Ir(biot-p-L)Cl]⊂Sav S112A-
K121A (Scheme 1c),25 afforded a modest TONIr of 69 
(6.9 % conversion) in the presence of 60 mM sodium 
formate (i.e. 120 mol%) (Scheme 3, entry 10, compare 
Table S7). 
Scheme 3. Transfer-hydrogenation coupled with 
NAD(P)H regeneration by a GDH and glucose (Glu). 
 
entry Sav   isoform 
Hydride 
source TONIr e.e. [%] 
1 No Sav NAD+/Glu     75 1 (R) 
2 WT NAD+/Glu   202   17 (S) 
3 S112A NAD+/Glu   214   8 (S) 
4 K121A NAD+/Glu   101   6 (S) 
5 K121R NAD+/Glu   270   13 (R) 
6 a K121R NAD+/Glu   679   13 (R) 
7a K121R NADP+/Glu   961   13 (R) 
8a, b K121R NADP+/Glu >999 14 (R) 
 9a ,c, d K121R NADP+/Glue   164   13 (R) 
10a ,f S112A-K121A HCOONa
g     69  6 (R) 
Experiments were performed at 25 or a 37 ºC for 14, b 16 
or c 24 h; 50 µM [Biot-Cp*Ir(L^L 5)Cl]⊂Sav variant, 0.1 
mg/ml GDH, 1 mM NAD(P)+, 50 mM MDQ A and 60 mM 
glucose in 0.3 M MOPS (pH 7.9). d100 µM [Biot-
Cp*Ir(L^L 5)Cl]⊂Sav. e 120 µM NADP+. f [Cp*Ir(biot-p-
L)Cl] was used instead of [Biot-Cp*Ir(L^L 5)]Cl. g 60 mM 
HCOONa. Average values for duplicate reactions are dis-
played; standard deviations were ≤ 4.0 %.  
However, the enantiomeric excess obtained via the 
above cascade was modest (Scheme 3 and Scheme 4, 
entry 4). To overcome this drawback, we integrated a 
monoamine oxidase (MAO) and a catalase, into the 
GDH/ATHase cascade for the production of MTQ B 
(Scheme 4).15,26 Combining the highly enantioselective 
MAO-catalyzed oxidation of (S)-MTQ B with simulta-
neous ATHase-driven reduction resulted in perfect enan-
tioselectivity to yield (R)-MTQ B in full conversion with 
only 2 equivalents of glucose required (Scheme 4, entry 
3). In this multienzymatic cascade reaction, the benefit 
of compartmentalizing the cofactor [Biot-Cp*Ir(L^L 
5)Cl] within Sav K121R is most prominent: the conver-
sion improved from a mere TONIr of at least 30 (6% 
yield) for the free cofactor to a TONIr of greater than 445 
(89% yield) with the ATHase (Scheme 4, entries 1, 2). 
Scheme 4. Enzyme cascade for the deracemization of 
cyclic amines.a)  
 







e.e.    
[%] 
1 No Sav 0.2 12     6 >99 (R) 
2 K121R 0.2 12   89   75 (R) 
3 K121R 0.2 24 >99 >99 (R) 
4 K121R – 24 >99   13 (R) 
a) Experiments were performed under the following condi-
tions; 100 µM [Biot-Cp*Ir(L^L 5)Cl], 0.1 mg/ml GDH, 0.2 
mg/ml MAO, 500U catalase, 1 mM NADP+, 50 mM MDQ 
A and 100 mM glucose in 0.3 M MOPS (pH 7.9) at 37 ºC. 
Average values for duplicate reactions are displayed and 
standard deviations were ≤ 1.0 %. 
Instead of GDH, we also coupled an alcohol dehydro-
genase (ADH), another representative NAD(P)H regen-
eration system, with the ATHase [Biot-Cp*Ir(L^L 5)Cl]
⊂Sav K121R. Relying on a hydrogen-borrowing strate-
gy,27 we designed a cascade reaction to enable a two 
step transformation of a linear aminoalcohol into a cy-
clic amine via an imine. For this purpose, 4-amino-1-
phenyl-1-butanol C was selected as a substrate (Scheme 
5a). In view of the exquisite enantioselectivity of ADH, 
one enantiomer of the aminoalcohol C is thought to be 
transformed into the corresponding dihydropyrrole D 
and pyrrolidine E in 12. 8% and 36.1 % yield respective-
ly after 48 h (Scheme 5b and Table S11).28 
Scheme 5. (a) A hydrogen-borrowing cascade reac-
tion comprised of an ADH with the NAD(P)H-
dependent ATHase and (b) its reaction progress: of 
2-phenyl-3,4-dihydro-5H-pyrrole D (red),  2-
phenylpyrrolidine E (cyan), and their sum (black).a)  
 
a) Experiments were performed at 37 ºC; 100 µM [Biot-
Cp*Ir(L^L 5)Cl]⊂Sav(K121R), 0.25 mg/ml ADH, 1 mM 
NADP+, 1.25 mM MgSO4, 10 mM substrate C in 0.3 M 
MOPS (pH 7.9). Average values for duplicate reactions are 
plotted; standard deviations were ≤ 0.23%. 
Finally, we investigated the transhydrogenase activity 
of the ATHase [Biot-Cp*Ir(L^L 5)Cl]⊂Sav K121R. 
Transhydrogenases rapidly equilibrate mixtures of 
NAD(H) and NADP(H) in a situation where one of 
NAD(H) and NADP(H) is more rapidly consumed than 
the other.29 In the absence of ATHase, the redox equili-
bration between NADPH and NAD+ or NADH and 
NADP+ was slow (Table 1, entries 2, 4). In contrast, 
[Biot-Cp*Ir(L^L 5)Cl]⊂Sav K121R significantly accel-
erates the reaction to reach its equilibrium within 30 min 
(Table 1, entries 1, 3 and Table S13). This transhydro-
genase activity may find applications to equilibrate the 
NAD(P)H levels in reaction cascades which combine 
both NADH- and NADPH-dependent enzymes. Exam-
ples include the biocatalytic synthesis of the potent drug 
hydromorphone30 or oxidation reactions catalyzed by 
P450 enzymes.31 
Table 1. Transhydrogenase activity of ATHase.a)  
entry catalyst reductant /substrate 
NADPH/NADH 
(mM) 
1 ATHase NADPH/NAD+ 1.9/2.4 
2 – NADPH/NAD+ 4.6/0.1 
3 ATHase NADH/NADP+ 1.9/2.4 
4 – NADH/NADP+ 0.1/4.7 
a) Experiments were performed at 37 ºC; 50 µM [Biot-
Cp*Ir(L^L 5)Cl]⊂Sav K121R, 5 mM NAD(P)H and 5 mM 
NAD(P)+ in 0.3 M MOPS (pH 7.9) for 30 min. Average 
 values for duplicate reactions are displayed and standard 
deviations were ≤ 1.0 %. 
In summary, NAD(P)H-dependent ATHases were 
successfully developed that allow the use of NAD(P)H 
as hydride source for transfer-hydrogenation under phys-
iological conditions. Two representative enzymatic 
NAD(P)H regeneration systems were shown to be com-
patible with this ATHase. A chemogenetic optimization 
strategy allowed to rapidly identify [Biot-Cp*Ir(L^L 
5)Cl]⊂Sav K121R as a versatile ATHase for the reduc-
tion of imines. Addition of a monoamine oxidase cou-
pled with a catalase allows to produce enantiopure 
amines as a result of a four enzyme cascade. Further 
researches to exploit this ATHase in vivo are in progress. 
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